Skip to main content
Top

Clinical & Experimental Metastasis

Issue 2/2000

Content (13 Articles)

Tissue inhibitors of metalloproteases: Regulation and biological activities

Gianfranco Fassina, Nicoletta Ferrari, Claudio Brigati, Roberto Benelli, Leonardo Santi, Douglas M. Noonan, Adriana Albini

Antioxidants inhibit TNFα-induced motility and invasion of human osteosarcoma cells: Possible involvement of NFκB activation

Katsumi Harimaya, Kazuhiro Tanaka, Yoshihiro Matsumoto, Hideshi Sato, Shuichi Matsuda, Yukihide Iwamoto

Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells

Qinghui Meng, Jingwen Xu, Itzhak D. Goldberg, Eliot M. Rosen, Robert A. Greenwald, Saijun Fan

Potentiation of antitumor effect of NKT cell ligand, α-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells1

Minoru Nakui, Akio Ohta, Masashi Sekimoto, Marimo Sato, Kenji Iwakabe, Takashi Yahata, Hidemitsu Kitamura, Toshiaki Koda, Tetsu Kawano, Hiroyasu Makuuchi, Masaru Taniguchi, Takashi Nishimura

Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines

Adriano Angelucci, Sandra D'Ascenzo, Claudio Festuccia, Giovanni Luca Gravina, Mauro Bologna, Vincenza Dolo, Antonio Pavan

Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro

Malika Balduyck, Farid Zerimech, Valérie Gouyer, Raphael Lemaire, Brigitte Hemon, Georges Grard, Carole Thiebaut, Véronique Lemaire, Evelyne Dacquembronne, Thérèse Duhem, Anne Lebrun, Marie-José Dejonghe, Guillemette Huet

Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: Implications for lymph node metastasis

Taketoshi Shimada, Hiroyuki Nakamura, Kaname Yamashita, Ryo Kawata, Yasushi Murakami, Noboru Fujimoto, Hiroshi Sato, Motoharu Seiki, Yasunori Okada

The microscopic anatomy of experimental rat CC531 colon tumour metastases: Consequences for immunotherapy?

Martin Hagenaars, N. Geeske Ensink, Per H. Basse, M. Hokland, U. Nannmark, Alexander M.M. Eggermont, Cornelis J.H. van de Velde, Gert Jan Fleuren, Peter J.K. Kuppen

Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma – diagnostic and prognostic implications

Heidi S. Berner, Ben Davidson, Aasmund Berner, Bjørn Risberg, Gunnar B. Kristensen, Claes G. Trope, Gregg Van de Putte, Jahn M. Nesland

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine